Status:
COMPLETED
Heparin's Influence on ROTEM® Analysis
Lead Sponsor:
University of Lausanne Hospitals
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-85 years
Brief Summary
Coagulopathy with transfusion requirements is frequent during cardiac surgery with cardiopulmonary Bypass. Rotational thromboelastrometry (ROTEM®) is a viscoelastic whole blood point of care test used...
Detailed Description
The Society of Cardiothoracic surgeons suggest that 50% of patients undergoing cardiac surgery have a blood transfusion. Several studies indicate an increase in morbidity and mortality related to blo...
Eligibility Criteria
Inclusion
- Patients ungergoing coronary artery bypass grafting using cardiopulmonary bypass
- Patients from 18 to 85 years old.
Exclusion
- Patients incapable to consent.
- Known coagulopathies or platelet dysfunction.
- Patients treated with antiplatelet drugs other than aspirin.
- Patients treated with anti vitamine K anticoagulants.
- Patients treated with heparin less than 6 hours prior to surgery.
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01455454
Start Date
September 1 2010
End Date
September 1 2011
Last Update
October 20 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Lausanne Hospitals
Lausanne, Canton of Vaud, Switzerland, 1011